Multifunctional nano-vaccines integrating lipid-conjugated tumor antigens with TLR/STING agonists enhance cancer immunotherapy

医学 免疫疗法 癌症免疫疗法 癌症研究 抗原 癌症 免疫系统 肿瘤相关抗原 肿瘤抗原 免疫学 单克隆抗体 抗体 细胞毒性 肿瘤免疫学 免疫原性 生物 肿瘤细胞
作者
Hari Krishnareddy Rachamala,Naga Malleswara Rao Nakka,Ramcharan Singh Angom,Fang Wei,Raj Nandani,Zain Toiemie,Edward S. Famularo,Shamit K. Dutta,Enfeng Wang,Santanu Bhattacharya,Krishnendu Pal,Keith L. Knutson,Debabrata Mukhopadhyay
出处
期刊:Cancer Letters [Elsevier BV]
卷期号:658: 218736-218736
标识
DOI:10.1016/j.canlet.2026.218736
摘要

: Although there are several ongoing clinical trials using neoantigen peptide-based cancer vaccines, challenges still exist to implement in clinical approval such as poor antigen stability, inefficient delivery, and inadequate immune activation. To address these limitations, we developed a polymer-based polyvalent peptide and adjuvant (SPPA) that co-delivers lipid-conjugated tumor-specific peptides with Toll-like receptor 7/8 (3M-052) and a STING (2′3′-cGAMP) agonist. This nanoplatform enables efficient peptide encapsulation, sustained release, and targeted delivery to antigen-presenting cells (APCs), thereby enhancing both innate and adaptive immune responses. We synthesized and characterized a library of lipid-conjugated tumor-associated and neoantigenic peptides. In vitro , SPPA significantly upregulated pro-inflammatory genes and cytokine secretion, confirming robust innate immune activation and demonstrated effective cellular uptake and lymphatic trafficking. In vivo , SPPA alone or in combination with anti-PD-1 antibody (αPD-1) elicited strong cytotoxic T lymphocyte (CTL) responses and inhibited tumor growth in four aggressive syngeneic mouse models: Triple-negative breast cancer (4T1), HER2 + breast cancer (TUBO), lung carcinoma (LLC1), and renal cell carcinoma (RENCA). The combination therapy led to pronounced tumor growth inhibition, survival benefit, and immune cell infiltration, including elevated CD8 + IFN-γ + T cells and M1 macrophages, and reduced regulatory T cells and MDSCs. Spatial transcriptomics revealed localized transcriptional reprogramming, with downregulation of extracellular matrix genes and activation of inflammatory pathways. Collectively, these findings establish SPPA as a potent and versatile nanovaccine platform capable of inducing durable antitumor immunity, especially when combined with immune checkpoint blockade. This approach offers strong translational potential for personalized immunotherapy across diverse solid tumor types.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Lucas的应助被今天不熬夜采纳,获得10
刚刚
咖喱完成签到,获得积分10
1秒前
liubole完成签到,获得积分10
1秒前
orixero的应助被yifei采纳,获得100
2秒前
ggb发布了新的文献求助10
2秒前
kovy完成签到 ,获得积分10
2秒前
二三清金完成签到 ,获得积分10
2秒前
luochenghao的应助被Yola采纳,获得10
3秒前
白昼懒得想完成签到,获得积分10
4秒前
4秒前
英姑的应助被船长采纳,获得10
5秒前
赘婿的应助被Wilson采纳,获得10
5秒前
wanci的应助被茶多酚采纳,获得10
5秒前
6秒前
VANNIE完成签到,获得积分10
6秒前
JamesPei的应助被丫丫采纳,获得10
6秒前
Cecilia完成签到 ,获得积分10
6秒前
7秒前
CodeCraft的应助被leehy采纳,获得10
7秒前
yangguang完成签到,获得积分10
8秒前
8秒前
morlison发布了新的文献求助10
8秒前
9秒前
zyt完成签到,获得积分10
10秒前
10秒前
搜集达人的应助被Power_Liu采纳,获得10
10秒前
孤独书翠完成签到,获得积分10
10秒前
123发布了新的文献求助10
10秒前
10秒前
科目三的应助被快乐的丹烟采纳,获得10
10秒前
斯文的帆布鞋完成签到,获得积分10
11秒前
星星完成签到,获得积分10
11秒前
极限001的应助被silica347采纳,获得100
12秒前
嘿1111完成签到,获得积分10
12秒前
12秒前
shuyiWang发布了新的文献求助10
13秒前
Wilson完成签到,获得积分10
13秒前
tiansun完成签到,获得积分10
13秒前
13秒前
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8160632
求助须知:如何正确求助?哪些是违规求助? 9555512
关于积分的说明 21728801
捐赠科研通 7750444
什么是DOI,文献DOI怎么找? 3427429
关于科研通互助平台的介绍 2552456
邀请新用户注册赠送积分活动 2471817